David A. Brown

Alston & Bird LLP

$ $$$

F Street Northwest 950
Washington 20004 DC US

David Brown focuses his practice on securities regulation, public and private mergers and acquisitions, public and private corporate finance transactions, friendly and hostile tender offers, proxy contests, going-private transactions, public company investments and general corporate matters.

He has extensive experience and knowledge in the federal securities laws, including the SEC’s tender offer rules, proxy rules, going private rules and the beneficial ownership rules.

Dave regularly advises a range of listed companies in SEC reporting and disclosure requirements, corporate governance issues, establishment of corporate compliance programs and other corporate and securities matters.

Additionally, Dave advises public and private companies and investment banking firms in mergers and acquisitions transactions. He also regularly advises hedge funds and other investment groups regarding the beneficial ownership rules and investments in public and private companies.

Dave received his J.D., cum laude, in 2003 from Brigham Young University, where he was a lead editor for the Journal of Public Law. He received a B.A. in history in 1999 from Brigham Young University.

Bar Admissions:

  •  District of Columbia
  •  Utah

Education:

  •  Brigham Young University (J.D., 2003)
  •  Brigham Young University (B.A., 1999)

Memberships:

  • District of Columbia Bar Association
  • Utah Bar Association
  • American Bar Association

EXPERIENCE:

  • Underwriters’ counsel in two offerings of a total of $5 billion of debt securities by the world’s best-known beverage company.
  • Counsel to the world’s largest beauty supply store in a $300 million secondary equity offering.
  • Counsel to a technology company for a $50 million self-tender offer of common stock.
  • Counsel to one of America’s largest full-service restaurant companies in proxy contest against dissident hedge funds.
  • Counsel to the director nominees of an acquirer in the successful hostile acquisition of a U.S. pharmaceutical company.

Cost

Rate : $$$$

Contact for details

Rate and write a review

Your email address will not be published. Required fields are marked *

Is this your profile?Claim it now.

Make sure your information is up to date.
F Street Northwest 950
Washington 20004 DC US
Get directions

Lina Stillman

5.0
Broadway 42
New York 10006 NY US
Advertisement